Hikma Pharma
A trading opportunity for you?
Will Hikma break support, or will it rise again back to highs of 2087p?
- Hikma has support since mid-August, 4 bounces off support zone, most recently last week.
- Now trading 1700p (at time of writing).
- Will the pattern repeat, the shares climbing back towards 2087p?
- Shares -19% from 2018 highs; +107.75% from 2018 lows; +49.8% year-to-date.
- 19 Nov: Hikma launches Triazolam Tablets
- 8 Nov: Panmure says Hikma is sensible partner for Vectura’s respiratory ambitions.
- Source: Bloomberg, FT, Reuters, DJ Newswires
Trading Hikma – An Example
Let’s say you like the Hikma chart and you think the price is heading back towards 2087p again. You decide to buy exposure to £10,000 worth of Hikma using a CFD, at the current price of 1700p. To do this, you need £2,000.
Let’s assume Hikma rises back to November high of 2087p (+22.7%). Your profit would be £2270, from your initial investment of £2,000.
Conversely, let’s assume you open the above position, and place a stop-loss at 9% from the current price. Hikma falls 9% and hits your stop-loss. Your loss would be £900.
This is provided for information purposes only. It should not be taken as a recommendation.

